Riyadh – Mubasher: The net profits attributable to the owners of Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) amounted to SAR 65.10 million in the first quarter (Q1) of 2026.
The quarterly profits were lower by 8.05% year-on-year (YoY) than SAR 70.80 million, according to the interim financial results.
The revenues totaled SAR 423.80 million in the January-March 2026 period, an annual drop of 12.58% from SAR 484.80 million.
Likewise, the earnings per share (EPS) went down to SAR 0.52 in Q1-26 from SAR 0.59 a year earlier.
Quarter-on-quarter (QoQ), the profits in Q1-26 hiked by 67.78% from SAR 38.80 million in Q4-25, while the revenues increased by 4.43% from SAR 405.80 million.
SPIMACO ended 2025 with 652.65% YoY higher net profits at SAR 184.40 million when compared with SAR 24.50 million.
